Consortium agreement

A consortium agreement in intellectual property matters is a contract that sets the intellectual property rules between the partners of a joint project. It determines how the partners will share and exploit the rights in the results of research and development.

Such contracts are also called research collaboration agreements. They are required in many innovative projects funded at national or European level, where the partners must formalise their cooperation.

This contractual grouping pools resources, allocates risks and organises ownership of the results. Unlike a company, however, the consortium has no legal personality: it rests on a contract that gives the project its legal structure.

Allocation of intellectual property rights

In the agreement, the parties first agree on the use of the research results, then designate the owner of the rights, and finally organise the sharing or transfer of those rights between the partners. Two fundamental concepts must be identified for that purpose: background and results.

Background

Background covers the know-how, patents, software or other elements a partner holds before joining the project. It is advisable to list it in an annex to the contract, distinguishing what the partner can make available from what is subject to restrictions, for instance because of third party rights. This precaution limits disputes over its origin or later use.

Results

Results are the data, creations or inventions obtained within the project. A result may be own, where a single partner developed it, or joint, where it results from common work. The distinction is crucial: it determines the allocation of rights, responsibility for filing titles (patents, software) and the terms of exploitation.

Protecting the results

The agreement may also protect trade secrets and the confidentiality of information. This is particularly true in sensitive technological fields such as artificial intelligence, blockchain or biotechnology, where the value of knowledge often lies in its confidential or novel character.

Where a result can be protected by an intellectual property right, such as a patent or software, the agreement sets the filing arrangements, the co-ownership rules and the organisation of commercialisation. The partners often designate a lead or managing partner, which centralises filings, annuity payments and renewals.

In case of co-ownership of joint results, the partners may negotiate an additional co-ownership agreement, setting each party’s share, the conditions of exploitation, the financial obligations and pre-emption rights in the event of an assignment to a third party.

Exploiting background and results

The agreement must also frame the use and commercial exploitation of background and results. Each partner generally has a right of access to the others’ elements in order to carry out the project. That right remains strictly limited and does not amount to an exploitation licence.

For commercial purposes, the agreement may provide for non-exclusive licences, usually of limited duration, on financial conditions « normal for the sector » set out in a separate agreement. In principle, any exclusive licence to a third party requires the prior consent of the other co-owners.

Waivers of patent filings must also be anticipated: a party that does not wish to file or maintain a title informs the others, who may then do so in their own name. A waiver limited to certain territories, however, leaves the co-ownership obligations standing in the other countries.

Securing partner entries and exits

These agreements allow partners to collaborate while protecting their intellectual property and provide a clear structure for managing and exploiting the results. They are found particularly in research and development projects bringing together companies, universities and research institutes.

The entry or departure of a partner is an often neglected but fundamental point. A new entrant may access existing background and results under conditions. A departing partner, by contrast, in principle loses its rights of access to and exploitation of the others’ elements, remains bound by the confidentiality clauses and must return or destroy sensitive documents.

Governance and liability

The terms of a consortium agreement vary greatly from one project to another, depending on the needs and contributions of each partner.

To ensure proper performance, the contract may create governance bodies: steering committee, scientific committee, publications committee. It defines their role, appointment and operating rules. The partners often also designate a coordinator for the technical and administrative follow-up of the grouping.

The contract also specifies the members’ liability: in principle, each partner answers for its own commitments. The parties often exclude any joint and several liability towards third parties and frequently limit recoverable losses, for instance loss of turnover or of customers.

Publication and confidentiality

Finally, the management of publications is another essential aspect. The agreement must reconcile scientific transparency with confidentiality and the prior filing of titles. A strict confidentiality clause is therefore indispensable to preserve the commercial value of the results.

The parties may also provide for a right of review over publications, notably for the industrial partners, so that no strategic or protectable information is disclosed too early. This control protects the intellectual property rights and ensures the consistency of the consortium’s communications.